BillionaireNet
Kirk
R
Rank #2287
UNITED STATESHealthcarePharmaceuticals

Randal J. Kirk

Net Worth
$1.638B
+0.83% (24h)
Randal J. Kirk is an American billionaire businessman and investor, primarily known for his ventures in the pharmaceuticals and biotechnology industries. Born on March 1, 1954, Kirk has built a substantial fortune through founding and investing in various companies. His career began in law, but he transitioned to entrepreneurship, founding General Injectables and Vaccines, New River Pharmaceuticals, and Third Security, LLC. A key player in Virginia's finance and biotech sectors, Kirk is recognized for his strategic investments and significant contributions to the field, including his involvement with Intrexon and Precigen. As of May 2024, his estimated net worth was $1.4 billion.

The Full Dossier

Early Life and Education

Randal J. Kirk was born on March 1, 1954, in Pleasanton, California. His family moved to Texas and later settled in Virginia. He graduated from Pulaski High School. Kirk began his higher education by selling cars and motorcycles while attending Radford University part-time. He earned a bachelor's degree in Economics from Radford University in 1976 and a Juris Doctor from the University of Virginia in 1979.

Rise to Success

After being admitted to the bar in 1980, Kirk started a law practice in Bland, Virginia. In 1983, he co-founded General Injectables and Vaccines, which was later sold. He founded New River Pharmaceuticals in 1996, and the company went public in 2004. The sale of New River Pharmaceuticals to Shire in 2007 for $2.6 billion was a major achievement, with Kirk earning over $1 billion from the deal. In 1999, he established Third Security, LLC, a life sciences investment firm. Kirk was the chairman and CEO of Intrexon, a biotechnology company, until 2020.

Key Business Strategies

Kirk is known for investing in small companies and staying with them until their products reach the market. He bet big on a few small companies and remained involved until products were ready for market. His investments often involved innovative products, such as genetically modified salmon and apples that resist browning.

Philanthropy

Kirk has made various philanthropic contributions. Following the sale of General Injectables and Vaccines, he donated $1 million to Radford University, creating the Zylphia Shu-En Kirk Endowment. He has also served on the boards of the Radford University Foundation and the University of Virginia. Kirk has also donated substantially to political causes.

Career Timeline

2020

Stepped down as CEO of Precigen

Remained as executive chairman.

2008

Chairman of Intrexon

Became chairman of the biotechnology company.

1999

Founded Third Security, LLC

Established a life sciences investment firm.

2007

Sold New River Pharmaceuticals

Sold to Shire for $2.6 billion, earning over $1 billion.

1996

Founded New River Pharmaceuticals

Served as chairman and CEO.

1983

Founded General Injectables and Vaccines

Co-founded the pharmaceutical distributor with John Gregory.

1980

Admitted to the bar

Became the only attorney in Bland, Virginia.

Philanthropic Impact

Education$1M

Zylphia Shu-En Kirk Endowment

Donation to Radford University

Wealth Trajectory